HM15912 / Hanmi  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
HM15912 / Hanmi
NCT04076293: Single Ascending Dose Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM15912 in Healthy Korean Subjects

Completed
1
40
RoW
HM15912, Placebo
Hanmi Pharmaceutical Company Limited
Pharmacology
11/20
11/20
NCT05711381: Phase 1 PK Study to Assess Safety, PK, Tolerability of HM15912 in Subjects With Renal Impairment and Normal Renal Function

Completed
1
16
US
HM15912
Hanmi Pharmaceutical Company Limited
Renal Impairment
08/23
08/23

Download Options